|
PELO expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.02429176251917E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
7.319100E-03 |
| Normal-vs-Stage3 |
1.55528999999932E-05 |
| Normal-vs-Stage4 |
1.994410E-02 |
| Stage1-vs-Stage2 |
5.284200E-03 |
| Stage1-vs-Stage3 |
1.619920E-03 |
| Stage1-vs-Stage4 |
6.21100000000041E-05 |
| Stage2-vs-Stage3 |
6.369400E-01 |
| Stage2-vs-Stage4 |
5.687200E-01 |
| Stage3-vs-Stage4 |
2.112600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.78701498043665E-12 |
| Normal-vs-AfricanAmerican |
5.443800E-04 |
| Normal-vs-Asian |
1.683190E-01 |
| Caucasian-vs-AfricanAmerican |
7.537800E-01 |
| Caucasian-vs-Asian |
8.475200E-01 |
| AfricanAmerican-vs-Asian |
7.834600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.85460005528182E-10 |
| Normal-vs-Female |
6.67799149312032E-12 |
| Male-vs-Female |
3.838200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.128040E-01 |
| Normal-vs-Age(41-60Yrs) |
1.65560010145782E-10 |
| Normal-vs-Age(61-80Yrs) |
5.3943960409697E-11 |
| Normal-vs-Age(81-100Yrs) |
6.701400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.617590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.426590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.172430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.505400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.978400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.448200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.04950001414517E-09 |
| Normal-vs-Grade 2 |
1.63025148935958E-12 |
| Normal-vs-Grade 3 |
4.82859996431273E-09 |
| Normal-vs-Grade 4 |
1.087000E-01 |
| Grade 1-vs-Grade 2 |
1.525990E-01 |
| Grade 1-vs-Grade 3 |
7.807500E-02 |
| Grade 1-vs-Grade 4 |
4.389900E-04 |
| Grade 2-vs-Grade 3 |
1.065650E-01 |
| Grade 2-vs-Grade 4 |
3.4223000000555E-06 |
| Grade 3-vs-Grade 4 |
4.255700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
7.75000000000636E-05 |
| ccA subtype-vs-ccB subtype |
1.14230000003435E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.32770033750762E-10 |
| Normal-vs-N1 |
7.530200E-01 |
| N0-vs-N1 |
5.829600E-02 |
|
|
